CRDMO providing integrated ADC and bioconjugate services from concept development through commercialization for biopharmaceutical partners. Co-located state-of-the-art labs and manufacturing on an open-access global platform to accelerate timelines, reduce costs, and deliver comprehensive capabilities and technologies.